Drug Profile
Isavuconazole - Astellas Pharma
Alternative Names: BAL 4815; Cresemba; RO 00 94815Latest Information Update: 26 Feb 2024
Price :
$50
*
At a glance
- Originator Basilea Pharmaceutica
- Developer Astellas Pharma; Basilea Pharmaceutica
- Class Antifungals; Benzonitrile; Pyridines; Small molecules; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Aspergillosis; Mycoses